Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Salmeterol vs Placebo in Exercise-Induced Bronchoconstriction
NCT00245570Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of montelukast in Exercise-induced bronchoconstriction (EIB) (6 arms), sponsored by Organon & Co. Primary endpoint: Maximum Percent Fall in Forced Expiratory Volume in 1 Second (FEV1) After Exercise Challenge. Started Dec 2005; status: completed.
02
Drugs
montelukast
03
Conditions
Exercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT00245570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245570.